Clinical Trial Update: Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 trial update of decitabine with or without valproic acid in myelodysplastic syndrome and acute myelogenous leukemia; completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Decitabine (Decitabine)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelodysplastic Syndrome, Acute Myelogenous Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2015-08-13